3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one

We are 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS:536760-29-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
CAS.NO: 536760-29-9
Synonyms:5-chloro-1-(4-nitrophenyl)-2,3-dihydropyridin-6-one
3-Chloro-1-(4-nitrophenyl)-5,6-dihydro-2(1H)-pyridinone
2(1H)-Pyridinone, 3-chloro-5,6-dihydro-1-(4-nitrophenyl)-
3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone

Molecular Formula:C11H9ClN2O3
Molecular Weight: 252.65400

Physical and Chemical Properties:
Density:1.5±0.1 g/cm3
Boiling point:412.2±45.0 °C at 760 mmHg
Melting point: /
Flash point: 203.1±28.7 °C
Refractive index: 1.638

Specification:
Appearance: White  powder
Purity: 98％
Water:0.5% Max.
Sulfated ash:0.1% Max.
Total Impurity:0.5% Max.

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Storage:2°C-8°C.Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Application:Intermediates of Apixaban CAS:503612-47-3

Related News: The purpose of APIs according to the FDA is to cause ‘pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.Cloruro de 4- (4,6-dimetoxi-1,3,5-triazin-2-il) -4-metilmorfolinio CAS:3945-69-5 The complete chemical and pharmaceutical industry chain consists of basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and chemical preparations.3387-36-8 “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.4FDCTZ CAS:51800-19-2 Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.We also have to consider the degree of concentration and which temperature allows a high quality of API to be manufactured efficiently.